Showing results (1-10 of 538) with videos related to
Sort By:
Pageof 54
Journal of Hematology & Oncology|March 19, 2025
Mirvetuximab soravtansine: current and future applicationsBeihua Kong, Wenxin ZhengGynecologic Oncology|September 4, 2012
Detection of PAX8 and p53 is beneficial in recognizing metastatic carcinomas in pelvic washings, especially in cases with suspicious cytologyLi Xiang, Wenxin Zheng, Beihua KongThe American Journal of Surgical Pathology|December 18, 2010
A proposed model for endometrial serous carcinogenesisWenxin Zheng, Li Xiang, Oluwole Fadare, et al.Journal of Hematology & Oncology|March 13, 2012
Ovarian serous carcinoma: recent concepts on its origin and carcinogenesisJie Li, Oluwole Fadare, Li Xiang, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2014
Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinomaLin Jia, Zeng Yuan, Yiying Wang, et al.International Journal of Clinical and Experimental Pathology|January 14, 2011
Nrf2 expression in endometrial serous carcinomas and its precancersNing Chen, Xiaofang Yi, Nisreen Abushahin, et al.Journal of Oncology|April 6, 2019
Tubal Origin of "Ovarian" Low-Grade Serous Carcinoma: A Gene Expression Profile StudyYiying Wang, Shuhui Hong, Jingyi Mu, et al.American Journal of Cancer Research|June 6, 2015
Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinomaYiying Wang, Maggie Mang, Yue Wang, et al.Histology and Histopathology|July 16, 2015
Ovarian serous carcinogenesis from tubal secretory cellsWenjing Zhang, Linxuan Wei, Lingmin Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2008
Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinomaLin Jia, Yongjuan Liu, Xiaofang Yi, et al.Pageof 54